White Papers for Food and Drug Administration (FDA)

This section of compliancehome.com gives you an access to a number of FDA Whitepaper, FDA Warning Letter. Most of the white papers enlisted in this section focus on topics like FDA Whitepaper, FDA Warning Letter regulator, FDA pharmaceutical, FDA products, FDA review, etc. The white paper that intends to provide a basic understanding of the rule and establish a framework from which a bar code system could be designed and implemented within medical facilities and certain other based on FDA Compliance for the life sciences are among hundreds of intellectual and helpful FDA whitepapers.

IT Risk Management Report 2: Myths and Realities
IT Risk - encompassing Security, Availability, Performance, and Compliance elements - has become a critical issue for executives and boards of directors. In this second volume of the IT Risk...

Lessons Learned for SOX Compliance and Other Regulatory Challenges
According to most estimates, first-year efforts to comply with the Sarbanes Oxley Act of 2002, widely known as “SOX,” tended to overcompensate by trying to cover too many controls. Stacks of...

Managing Access to Critical Data for Protection and Privacy
Protecting intellectual property and confidential personal, financial, and business information is a business priority, and often a legal requirement. To secure their data and ensure that on...

Symantec Endpoint Protection: A unified, proactive approach to endpoint security
Organizations today face a threat landscape that involves stealthy, targeted, and financially motivated attacks that exploit vulnerabilities in endpoint devices. Many of these sophisticated ...

Symantec Network Access Control Comprehensive Network Access Control
The managed state of an organization’s individual endpoints plays a critical role in the overall security and availability of its IT infrastructure and related business operations. The new w...

Taking Action to Protect Sensitive Data
Only 12 percent of organizations—about one in ten—are experiencing fewer than three losses of sensitive data in the past year. For all other institutions—almost 90 percent—data loss rates ar...

Why Compliance Pays: Reputations and Revenues at Risk - Research Report
The amount spent on compliance and data protection is a very small percentage of the financial value that is at risk. With returns on investment in compliance for larger enterprises starting...

10 Steps To Business-Driven Compliance
A fundamental fallacy is harming large, established businesses and threatening to destroy emerging ones. That fallacy is: when the regulators and their regulations come calling: (1) you must...

15 Common Mistakes in Web Security: Enterprise vulnerabilities that invite attack
Web 2.0 applications provide access to numerous resources. From social networks to blogs, to wikis, employees are surfing the web for business data and for personal use. However, web-born...

21 CFR Part 11: Are You Ready for an FDA Inspection?
Organizations regulated by the U.S. Food and Drug Administration (FDA) like pharmaceutical, biotechnology, medical device, and others continue to experience the peaks and valleys of complyin...